NCT01161602View on ClinicalTrials.gov

A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of Pumosetrag in Patients With Gastroesophageal Reflux Disease (GERD)

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Study Completion Date

May 31, 2011

Conditions
Gastroesophageal Reflux Disease
Interventions
DRUG

Pumosetrag

DRUG

Pumosetrag

OTHER

Placebo

DRUG

Pumosetrag

Trial Locations (5)

55905

Mayo Clinic Rochester, Rochester

73112

Lynn Health Science Institute, Oklahoma City

85259

Mayo Clinic Scottsdale, Scottsdale

92801

Advanced Clinical Research Institute, Anaheim

Unknown

Mayo Clinic Jacksonville, Jacksonville

Sponsors
All Listed Sponsors
lead

Edusa Pharmaceuticals, Inc.

INDUSTRY